Author

Dyonissios Katsaros

University of Turin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexandra IngallinellaiD· 1 shared Angela CelettiiD· 1 shared Anna SpinaiD· 1 shared Benedetta PellegrinoiD· 1 shared Camilla NeroiD· 1 shared Carmela BavielloiD· 1 shared Daniela CalifanoiD· 1 shared Daniela CriscuoloiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra IngallinellaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Using CCDC6 immunostaining in conjunction with the RAD51 HRD assay as a novel approach to expand PARPi treatment eligibility in HGSOC patients

Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, Luca Russolillo, Ilaria De Benedictis, Daniela Califano, Rosaria Catalano, Carmela Baviello, Silvia Varricchio, Sabrina Chiara Cecere, Camilla Nero, Eleonora Palluzzi, Dyonissios Katsaros, E. Capoluongo, Giovanni Luca Scaglione, , Angela Celetti

The paper investigates CCDC6 mutations in HGSOC and shows their link to HRD and PARPi sensitivity, even in BRCA1/2 wild-type patients.

bioRxiv · Jul 29, 2025 · PreprintCancer Biology